152 related articles for article (PubMed ID: 10521993)
1. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
[TBL] [Abstract][Full Text] [Related]
2. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
[TBL] [Abstract][Full Text] [Related]
3. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
5. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
6. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
7. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
9. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Cytokine; 2001 Jun; 14(6):343-6. PubMed ID: 11497495
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
11. Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):159-65. PubMed ID: 10560618
[TBL] [Abstract][Full Text] [Related]
12. Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.
Chow HH; Earnest DL; Clark D; Mason-Liddil N; Kramer CB; Einspahr JG; Guillen-Rodriguez JM; Roe DJ; Malone W; Crowell JA; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):351-6. PubMed ID: 10794478
[TBL] [Abstract][Full Text] [Related]
13. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
14. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
[TBL] [Abstract][Full Text] [Related]
15. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.
Wiercinska-Drapalo A; Jaroszewicz J; Tarasow E; Flisiak R; Prokopowicz D
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):160-8. PubMed ID: 16303613
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic and histological patchiness in treated ulcerative colitis.
Kim B; Barnett JL; Kleer CG; Appelman HD
Am J Gastroenterol; 1999 Nov; 94(11):3258-62. PubMed ID: 10566726
[TBL] [Abstract][Full Text] [Related]
18. High-magnification chromoscopic colonoscopy in ulcerative colitis: a valid tool for in vivo optical biopsy and assessment of disease extent.
Hurlstone DP; Sanders DS; McAlindon ME; Thomson M; Cross SS
Endoscopy; 2006 Dec; 38(12):1213-7. PubMed ID: 17163321
[TBL] [Abstract][Full Text] [Related]
19. Studies of rectal mucosal catecholamines in ulcerative colitis.
Penttilä O; Kyösola K; Klinge E; Ahonen A; Tallqvist G
Ann Clin Res; 1975 Feb; 7(1):32-6. PubMed ID: 1155909
[TBL] [Abstract][Full Text] [Related]
20. The importance of recognizing increased cecal inflammation in health and avoiding the misdiagnosis of nonspecific colitis.
Paski SC; Wightman R; Robert ME; Bernstein CN
Am J Gastroenterol; 2007 Oct; 102(10):2294-9. PubMed ID: 17608777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]